Fri, Aug 22, 2014, 7:44 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Isis Pharmaceuticals, Inc. Message Board

  • monkeysdolie monkeysdolie Jan 16, 2013 10:38 AM Flag

    By pushing the price up will not save isis from the lawyers. The damage has been done by hiding the facts.

    Class action payoff to show it soes not pay to mislead. #$%$ controls the board so he will get more bonuses no matter how much damage he did.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • My take is, the first filer cannot find a plaintiff. Tells you something. Kynamro gets approved, tells you something more. To try to take that to court, it will get dismissed on first motion to dismiss. ISIS could counter sue for frivilous suit and they would win. 200 Billion in damages because that is the potential damage to their market cap, via, damage to their rep. A reminder to the class action peeps to get an expert opinion first, then sue. Panel opinions for purpose of a license are not the same thing. Expert for litigation has to take into account safe harbor, and all info one could obtain through FOIA. Non public info is then able to be proven, and its impact. See? Duhhh?

      Sentiment: Strong Buy

 
ISIS
34.33+0.16(+0.47%)Aug 22 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.